NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Tuesday that its fourth quarter revenues rose 7 percent year over year, in line with preliminary Q4 revenues reported in January.

For the three months ended Dec. 31, the company reported revenues of $16.0 million, up from $14.9 million in Q4 2016, and beating the analysts' consensus estimate of $15.6 million for the quarter.